Ophthalmic cyclosporine in equine keratitis and keratouveitis: 11 cases.

This research investigates the use of topical cyclosporine A for treating various eye diseases in horses and concludes it to be mostly effective and safe, encouraging further exploration into its use as an ocular immunosuppressant.

Objective and Methodology

• The researchers intended to evaluate the safety, effectiveness, and potential use of topical cyclosporine A in treating ocular conditions in horses.
• This drug was administered in 11 equine cases presenting with keratitis and keratouveitis, which are inflammation conditions of the eye.
• The specific diagnoses among these cases included interstitial keratouveitis, endotheliitis, multifocal punctate keratopathy, and a melting stromal ulcer.

Findings and Implications

• Out of the 11 cases, topical cyclosporine A appeared to be effective as an anti-inflammatory agent in 9 cases, demonstrating its potential use in the treatment of equine ocular inflammation.
• However, in most cases, it remained uncertain whether an insidious bacterial infection was present or absent. This aspect is crucial as it may influence the overall response to the drug.
• Importantly, throughout the study, it was found that cyclosporine A had no harmful effects on the animals, thus indicating its safe usage in horses.
• Given these results, the authors suggest that cyclosporine’s utility in both aqueous and lipid-based formulations should be explored in the future. This is to assess if it can serve as an alternative technique for bringing about ocular immunosuppression in equines.
• Ocular immunosuppression could be beneficial in managing and treating inflammatory or autoimmune conditions affecting the eyes of horses.

Conclusions

• Overall, the study supports the use of topical cyclosporine A in equine ocular treatment, proving its safety and efficacy in most cases.
• Further research is needed to assess its use in different formulations and to conclusively ascertain its role in managing bacterial infections commonly associated with ocular conditions.